GlassScriptPrepare for your visit
Eric P Reintsema
Family Medicine · North Port, FL · NPI 1538160411
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$576.74
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- Glaxosmithkline, LLC. $144.46
- Lilly USA, LLC $95.99
- Boston Scientific Corporation $90.27
- Astrazeneca Pharmaceuticals LP $39.55
- Pfizer INC. $36.10
- Boehringer Ingelheim Pharmaceuticals, INC. $35.67
Drugs and devices associated with these payments
Trelegy Ellipta Watchman Flx Mounjaro Jardiance Paxlovid Breztri Cologuard Collection Kit Intellis Adaptivestim Synjardy Yupelri Prevnar 20 Comirnaty
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Eric Reintsema listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/748924/eric-p-reintsema